Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis

Detection of pyrazinamide heteroresistance in Mycobacterium tuberculosis

Aim: Pyrazinamide (PZA) is a first-line key agent in the effective treatment of tuberculosis (TB), including PZA susceptible multidrug-resistant tuberculosis (MDR-TB). Occasionally, TB patients might have mixed infections with both drug-sensitive and -resistant strains. This is termed heteroresistan...

Full description

Bibliographic Details
Main Authors: Mikaela Glader, Sven Hoffner, Jim Werngren
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2015-01-01
Series:International Journal of Mycobacteriology
Subjects:
M. tuberculosis
Pyrazinamide
Drug susceptibility testing
Heteroresistance
Online Access:http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=29;epage=29;aulast=Glader;type=0

Internet

http://www.ijmyco.org/article.asp?issn=2212-5531;year=2015;volume=4;issue=5;spage=29;epage=29;aulast=Glader;type=0

Similar Items